Key points Real-world studies show high discontinuation rates for glucagon-like peptide 1 receptor agonists (GLP1RAs) and tirzepatide, particularly among individuals without type 2 diabetes mellitus who are using these drugs to treat obesity
Track your symptoms for 23 weeks after beginning any fasting protocol: document hunger levels, energy, nausea, and digestion quality
However, strong acids or oxidising agents should be avoided in parallel use, as they can destabilise peptide molecules
Practical ways to manage it Several strategies can help reduce the frequency and severity of diarrhea: Eat smaller, more frequent meals : Large meals put extra strain on a digestive system that is already adjusting to the medication
In addition, lifestyle optimizers people who value structure in their nutrition, activity, and supplementation are finding appeal in solutions that integrate seamlessly into existing habits